MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
MindMed, a clinical-stage biopharmaceutical company, revealed that its management team will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference. This event takes place on June 27, 2024. The presentation will be accessible via a webcast on MindMed’s Investor Relations website starting at 7:00 AM ET on the same date. The webcast will remain available for replay for up to 90 days post-event.
- None.
- None.
A webcast of the fireside chat will be accessible on MindMed’s Investor Relations website starting on June 27, 2024 at 7:00 AM ET and will remain available for replay on the website for up to 90 days following the event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240621380316/en/
For Media: media@mindmed.co
For Investors: ir@mindmed.co
Source: Mind Medicine Inc.
FAQ
When will MindMed present at the H.C. Wainwright Neuro Perspectives Virtual Conference?
Where can I watch the MindMed presentation from the H.C. Wainwright Neuro Perspectives Virtual Conference?
How long will the MindMed webcast be available for replay?
What is the stock symbol for MindMed?